Research and Markets: Chinese Markets for Asthma Treatment Drugs Report Gives Long-term Forecasts through 2016 and 2021

Posted: Published on October 8th, 2012

This post was added by Dr P. Richardson

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tr5tkv/chinese_markets) has announced the addition of the "Chinese Markets for Asthma Treatment Drugs" report to their offering.

China's demand for asthma treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Companies Mentioned

Beijing SL Pharmaceutical Co., Ltd

Yangtze River Pharmaceutical Group

Hangzhou Aoyipollen Pharmaceutical Co., Ltd.

Zhuhai Union Pharmaceutical Co., Ltd

Shandong Qilu Pharmaceutical Co., Ltd

Chengdu Minyi Pharmaceutical Co., Ltd

See more here:
Research and Markets: Chinese Markets for Asthma Treatment Drugs Report Gives Long-term Forecasts through 2016 and 2021

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.